pubmed-article:20981219 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20981219 | lifeskim:mentions | umls-concept:C0019169 | lld:lifeskim |
pubmed-article:20981219 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:20981219 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:20981219 | lifeskim:mentions | umls-concept:C0015624 | lld:lifeskim |
pubmed-article:20981219 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:20981219 | lifeskim:mentions | umls-concept:C0540694 | lld:lifeskim |
pubmed-article:20981219 | lifeskim:mentions | umls-concept:C0439590 | lld:lifeskim |
pubmed-article:20981219 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:20981219 | pubmed:dateCreated | 2010-10-28 | lld:pubmed |
pubmed-article:20981219 | pubmed:abstractText | Adefovir dipivoxil (ADV) is commonly used as an antiviral agent in the treatment of chronic hepatitis B or human immunodeficiency virus infection. Nephrotoxicity has been shown to occur at daily dosages of 60-120 mg. Fanconi's syndrome is a generalized dysfunction of the renal proximal tubular cells, which is usually accompanied by complications. Here we report a case of Fanconi's syndrome in a chronic hepatitis B patient who had been treated with a prolonged regimen of ADV at 10 mg/day. A 47-year-old man complained of severe back and chest-wall pain. He had chronic hepatitis B and had been treated with ADV at a daily dose of 10 mg for 38 months. He was hospitalized because of severe bone pain, and laboratory and radiologic findings suggested a diagnosis of Fanconi's syndrome with osteomalacia. After discontinuation of the ADV, he recovered and was discharged from hospital. His laboratory findings had normalized within 2 weeks. This case indicates that Fanconi's syndrome can be acquired by a chronic hepatitis B patient taking ADV at a conventional dosage of 10 mg/day. Therefore, patients treated with long-term ADV should be checked regularly for the occurrence of ADV-induced Fanconi's syndrome. | lld:pubmed |
pubmed-article:20981219 | pubmed:language | eng | lld:pubmed |
pubmed-article:20981219 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20981219 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
pubmed-article:20981219 | pubmed:month | Sep | lld:pubmed |
pubmed-article:20981219 | pubmed:issn | 1976-2283 | lld:pubmed |
pubmed-article:20981219 | pubmed:author | pubmed-author:ParkJong... | lld:pubmed |
pubmed-article:20981219 | pubmed:author | pubmed-author:KimJi HoonJH | lld:pubmed |
pubmed-article:20981219 | pubmed:author | pubmed-author:KimJae SeonJS | lld:pubmed |
pubmed-article:20981219 | pubmed:author | pubmed-author:YeonJong... | lld:pubmed |
pubmed-article:20981219 | pubmed:author | pubmed-author:ByunKwan... | lld:pubmed |
pubmed-article:20981219 | pubmed:author | pubmed-author:BakYoung-TaeY... | lld:pubmed |
pubmed-article:20981219 | pubmed:author | pubmed-author:KimChung HoCH | lld:pubmed |
pubmed-article:20981219 | pubmed:author | pubmed-author:JungEun SukES | lld:pubmed |
pubmed-article:20981219 | pubmed:author | pubmed-author:JungYoung... | lld:pubmed |
pubmed-article:20981219 | pubmed:author | pubmed-author:ChoiJong... | lld:pubmed |
pubmed-article:20981219 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:20981219 | pubmed:volume | 4 | lld:pubmed |
pubmed-article:20981219 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20981219 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20981219 | pubmed:pagination | 389-93 | lld:pubmed |
pubmed-article:20981219 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20981219 | pubmed:articleTitle | Fanconi's Syndrome Associated with Prolonged Adefovir Dipivoxil Therapy in a Hepatitis B Virus Patient. | lld:pubmed |
pubmed-article:20981219 | pubmed:affiliation | Department of Internal Medicine, Gachon University of Medicine and Science Gil Medical Center, Incheon, Korea. | lld:pubmed |
pubmed-article:20981219 | pubmed:publicationType | Journal Article | lld:pubmed |